Cargando…

Waning immunity to SARS-CoV-2: implications for vaccine booster strategies

Detalles Bibliográficos
Autores principales:	Altmann, Daniel M, Boyton, Rosemary J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8530466/ https://www.ncbi.nlm.nih.gov/pubmed/34688435 http://dx.doi.org/10.1016/S2213-2600(21)00458-6

Ejemplares similares

SARS-Cov-2 immune waning and reinfection in care-home settings
por: Altmann, Daniel M, et al.
Publicado: (2021)

Risk of SARS-CoV-2 reinfection after natural infection
por: Boyton, Rosemary J, et al.
Publicado: (2021)

Vaccine efficacy and immune interference: co-administering COVID-19 and influenza vaccines
por: Altmann, Daniel M, et al.
Publicado: (2022)

Managing waning vaccine protection against SARS-CoV-2 variants
por: Leung, Kathy, et al.
Publicado: (2022)

Redirected vaccine imprinting by co-administration of COVID-19 and influenza vaccines
por: Boyton, Rosemary J., et al.
Publicado: (2023)

Waning immunity to inactive SARS-CoV-2 vaccine in healthcare workers: booster required
por: Balkan, İlker İnanc, et al.
Publicado: (2022)

Imprinted hybrid immunity against XBB reinfection
por: Boyton, Rosemary J, et al.
Publicado: (2023)

Bivalent omicron (BA.1) booster vaccination against SARS-CoV-2
por: Vasin, Andrey V, et al.
Publicado: (2023)

What policy makers need to know about COVID-19 protective immunity
por: Altmann, Daniel M, et al.
Publicado: (2020)

Implications of COVID-19 vaccine effectiveness waning for public health
por: Odone, Anna, et al.
Publicado: (2022)

Waning of SARS-CoV-2 booster viral-load reduction effectiveness
por: Levine-Tiefenbrun, Matan, et al.
Publicado: (2022)

Waning effectiveness of COVID-19 vaccines
por: Chemaitelly, Hiam, et al.
Publicado: (2022)

The immunology of asymptomatic SARS-CoV-2 infection: what are the key questions?
por: Boyton, Rosemary J., et al.
Publicado: (2021)

Waning immunity to SARS-CoV-2 following vaccination or infection
por: Hernandez-Suarez, Carlos, et al.
Publicado: (2022)

SARS‐CoV‐2 booster effect and waning immunity in hemodialysis patients: A cohort study
por: Goggins, Eibhlin, et al.
Publicado: (2023)

SARS-CoV-2 vaccine strategies in kidney transplant recipients
por: Prendecki, Maria, et al.
Publicado: (2023)

Behaviour, booster vaccines and waning immunity: modelling the medium-term dynamics of SARS-CoV-2 transmission in England in the Omicron era
por: Barnard, Rosanna C., et al.
Publicado: (2022)

An intranasal lentiviral booster reinforces the waning mRNA vaccine-induced SARS-CoV-2 immunity that it targets to lung mucosa
por: Vesin, Benjamin, et al.
Publicado: (2022)

Booster dose of mRNA vaccine augments waning T cell and antibody responses against SARS-CoV-2
por: Özbay Kurt, Feyza Gül, et al.
Publicado: (2022)

Modeling of waning immunity after SARS-CoV-2 vaccination and influencing factors
por: Pérez-Alós, Laura, et al.
Publicado: (2022)

SARS-CoV-2 variants: Subversion of antibody response and predicted impact on T cell recognition
por: Altmann, Daniel M., et al.
Publicado: (2021)

Challenges in creating herd immunity to SARS-CoV-2 infection by mass vaccination
por: Anderson, Roy M, et al.
Publicado: (2020)

Vaccination and protective immunity to SARS-CoV-2 omicron variants in people with immunodeficiencies
por: Nadesalingam, Angalee, et al.
Publicado: (2023)

Vaccination strategies for mitigation of MERS-CoV outbreaks
por: Bosaeed, Mohammad, et al.
Publicado: (2023)

Waning of COVID-19 vaccine effectiveness: individual and public health risk
por: Piechotta, Vanessa, et al.
Publicado: (2022)

Dynamics of SARS-CoV-2 with waning immunity in the UK population
por: Crellen, Thomas, et al.
Publicado: (2021)

Protection and Waning of Natural and Hybrid Immunity to SARS-CoV-2
por: Goldberg, Yair, et al.
Publicado: (2022)

Waning and boosting of functional humoral immunity to SARS-CoV-2
por: Tong, X., et al.
Publicado: (2022)

Bell's palsy and SARS-CoV-2 vaccines
por: Ozonoff, Al, et al.
Publicado: (2021)

SARS-CoV-2 vaccination in people with HIV
por: Spinelli, Matthew A
Publicado: (2021)

Optimising SARS-CoV-2 vaccination schedules
por: Belda-Iniesta, Cristobal
Publicado: (2021)

Comparative systematic review and meta-analysis of reactogenicity, immunogenicity and efficacy of vaccines against SARS-CoV-2
por: McDonald, Ian, et al.
Publicado: (2021)

The accelerated waning of immunity and reduced effect of booster in patients treated with bDMARD and tsDMARD after SARS-CoV-2 mRNA vaccination
por: Tobudic, Selma, et al.
Publicado: (2023)

SARS-CoV-2: from herd immunity to hybrid immunity
por: Goldblatt, David
Publicado: (2022)

Recombinant protein vaccines against SARS-CoV-2
por: Gilbert, Sarah C, et al.
Publicado: (2021)

SARS-CoV-2 evolution and vaccines: cause for concern?
por: Williams, Thomas C, et al.
Publicado: (2021)

Stroke after SARS-CoV-2 vaccination: Comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Rapid Waning of Immune Memory Against SARS-CoV-2 in Maintenance Hemodialysis Patients After mRNA Vaccination and Impact of a Booster Dose
por: Espi, Maxime, et al.
Publicado: (2023)

Hybrid immunity versus vaccine-induced immunity against SARS-CoV-2 in patients with autoimmune rheumatic diseases
por: Shenoy, Padmanabha, et al.
Publicado: (2022)

Natural immunity helps overcome the age-related decline of SARS-CoV-2 vaccine immunogenicity
por: Verschoor, Chris P, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vtdinljkp61q3amgs5h6arlf1s